Peter Svennilson, 10% Owner, Director, Ten Percent Owner Other at NGM BIOPHARMACEUTICALS INC (NGM), bought 298,392 shares at $13.20 ($4.0M) on 2022-05-18, disclosed to the SEC on 2022-05-19.
Open-market purchase of $4.0M NGM by 10% Owner, Director, Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.42 | 2,939 | $39K | 1.0% |
| 2 | $13.42 | 86,110 | $1.2M | 29.1% |
| 3 | $13.42 | 86,110 | $1.2M | 29.1% |
| 4 | $13.20 | 2,067 | $27K | 0.7% |
| 5 | $13.20 | 60,583 | $800K | 20.1% |
| 6 | $13.20 | 60,583 |
| $800K |
| 20.1% |
| Total | $13.33 avg | 298,392 | $4.0M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |
| RVMD | SELL | 2021-04-28 | $6.5M | — | Filing → |